News brief
On 2026/10/8, AIPressRoom reported that Multiply Labs raised USD 75 million in Series B funding, led by Patrick Soon-Shiong and NantWorks. It uses robotic systems to automate biologic drug production, improving pharmaceutical manufacturing efficiency and quality consistency.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- aipressroom.com ↗Published Oct 8, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年10月8日，据AIPressRoom报道，Multiply Labs完成7500万美元B轮融资，由Patrick Soon-Shiong与NantWorks领投。公司用机器人系统自动化生物药生产，提高制药制造效率与质量一致性。